Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Expert Review of Respiratory Medicine
|
May 16, 2024
Unmet challenges in cystic fibrosis treatment with modulators
Federica Corrao, Mairead Kelly-Aubert, Isabelle Sermet-Gaudelus, et al.
Journal of Physiology and Biochemistry
|
April 8, 2022
Aging modifies receptor expression but not muscular contractile response to angiotensin II in rat jejunum
Maria Grazia Zizzo, Adele Cicio, Federica Corrao, et al.
IUBMB Life
|
June 6, 2025
Nonsense Mutations in Rare and Ultra-Rare Human Disorders: An Overview
Emanuele Vitale, Davide Ricci, Federica Corrao, et al.
IUBMB Life
|
May 27, 2025
Advancing Therapeutic Strategies for Nonsense-Related Diseases: From Small Molecules to Nucleic Acid-Based Innovations
Davide Ricci, Ilenia Cruciata, Ignazio Fiduccia, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
October 30, 2024
Promoting readthrough of nonsense mutations in CF mouse model: Biodistribution and efficacy of NV848 in rescuing CFTR protein expression
Ignazio Fiduccia, Federica Corrao, Maria Grazia Zizzo, et al.
International Journal of Molecular Sciences
|
October 28, 2023
Readthrough Approach Using NV Translational Readthrough-Inducing Drugs (TRIDs): A Study of the Possible Off-Target Effects on Natural Termination Codons (NTCs) on TP53 and Housekeeping Gene Expression
Riccardo Perriera, Emanuele Vitale, Ivana Pibiri, et al.
International Journal of Molecular Sciences
|
June 10, 2023
Investigating the Inhibition of FTSJ1, a Tryptophan tRNA-Specific 2'-O-Methyltransferase by NV TRIDs, as a Mechanism of Readthrough in Nonsense Mutated CFTR
Pietro Salvatore Carollo, Marco Tutone, Giulia Culletta, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
October 20, 2022
Nonsense codons suppression. An acute toxicity study of three optimized TRIDs in murine model, safety and tolerability evaluation
Federica Corrao, Maria Grazia Zizzo, Marco Tutone, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
March 30, 2025
A precision medicine approach to primary immunodeficiency disease: Ataluren strikes nonsense mutations once again
Laura Lentini, Riccardo Perriera, Federica Corrao, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Expert Review of Respiratory Medicine
|
May 16, 2024
Unmet challenges in cystic fibrosis treatment with modulators
Federica Corrao, Mairead Kelly-Aubert, Isabelle Sermet-Gaudelus, et al.
Journal of Physiology and Biochemistry
|
April 8, 2022
Aging modifies receptor expression but not muscular contractile response to angiotensin II in rat jejunum
Maria Grazia Zizzo, Adele Cicio, Federica Corrao, et al.
IUBMB Life
|
June 6, 2025
Nonsense Mutations in Rare and Ultra-Rare Human Disorders: An Overview
Emanuele Vitale, Davide Ricci, Federica Corrao, et al.
IUBMB Life
|
May 27, 2025
Advancing Therapeutic Strategies for Nonsense-Related Diseases: From Small Molecules to Nucleic Acid-Based Innovations
Davide Ricci, Ilenia Cruciata, Ignazio Fiduccia, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
October 30, 2024
Promoting readthrough of nonsense mutations in CF mouse model: Biodistribution and efficacy of NV848 in rescuing CFTR protein expression
Ignazio Fiduccia, Federica Corrao, Maria Grazia Zizzo, et al.
International Journal of Molecular Sciences
|
October 28, 2023
Readthrough Approach Using NV Translational Readthrough-Inducing Drugs (TRIDs): A Study of the Possible Off-Target Effects on Natural Termination Codons (NTCs) on TP53 and Housekeeping Gene Expression
Riccardo Perriera, Emanuele Vitale, Ivana Pibiri, et al.
International Journal of Molecular Sciences
|
June 10, 2023
Investigating the Inhibition of FTSJ1, a Tryptophan tRNA-Specific 2'-O-Methyltransferase by NV TRIDs, as a Mechanism of Readthrough in Nonsense Mutated CFTR
Pietro Salvatore Carollo, Marco Tutone, Giulia Culletta, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
October 20, 2022
Nonsense codons suppression. An acute toxicity study of three optimized TRIDs in murine model, safety and tolerability evaluation
Federica Corrao, Maria Grazia Zizzo, Marco Tutone, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
March 30, 2025
A precision medicine approach to primary immunodeficiency disease: Ataluren strikes nonsense mutations once again
Laura Lentini, Riccardo Perriera, Federica Corrao, et al.
Page
of 1